Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2022)

Top pharmaceutical retailer stocks in 2022 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

According to Zen Score, the 3 best drug store stocks to buy right now are:

Walgreens Boots Alliance (NASDAQ:WBA) is the top pharmaceutical retailer stock with a Zen Score of 49, which is 20 points higher than the pharmaceutical retailer industry average of 29. It passed 17 out of 38 due diligence checks and has strong fundamentals. Walgreens Boots Alliance has seen its stock lose -35.23% over the past year, overperforming other pharmaceutical retailer stocks by 27 percentage points.

Walgreens Boots Alliance has an average 1 year price target of $43.89, an upside of 39.11% from Walgreens Boots Alliance's current stock price of $31.55.

Walgreens Boots Alliance stock has a consensus Hold recommendation according to Wall Street analysts. Of the 9 analysts covering Walgreens Boots Alliance, 0% have issued a Strong Buy rating, 0% have issued a Buy, 88.89% have issued a hold, while 0% have issued a Sell rating, and 11.11% have issued a Strong Sell.

Petmed Express (NASDAQ:PETS) is the second best pharmaceutical retailer stock with a Zen Score of 46, which is 17 points higher than the pharmaceutical retailer industry average of 29. It passed 15 out of 38 due diligence checks and has strong fundamentals. Petmed Express has seen its stock lose -29.61% over the past year, overperforming other pharmaceutical retailer stocks by 32 percentage points.

Petmed Express has an average 1 year price target of $26.33, an upside of 33.6% from Petmed Express's current stock price of $19.71.

Petmed Express stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Petmed Express, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

High Tide (NASDAQ:HITI) is the third best pharmaceutical retailer stock with a Zen Score of 33, which is 4 points higher than the pharmaceutical retailer industry average of 29. It passed 10 out of 33 due diligence checks and has average fundamentals. High Tide has seen its stock lose -77.65% over the past year, underperforming other pharmaceutical retailer stocks by -16 percentage points.

High Tide has an average 1 year price target of $4.45, an upside of 224.82% from High Tide's current stock price of $1.37.

High Tide stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

Petmed Express (NASDAQ:PETS) has an annual dividend yield of 6.09%, which is the same as the pharmaceutical retailer industry average of 6.08%. Petmed Express's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Petmed Express's dividend has shown consistent growth over the last 10 years.

Petmed Express's dividend payout ratio of 125% indicates that its high dividend yield might not be sustainable for the long-term.

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 6.06%, which is the same as the pharmaceutical retailer industry average of 6.08%. Walgreens Boots Alliance's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Walgreens Boots Alliance's dividend has shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of 30.8% indicates that its high dividend yield is sustainable for the long-term.

Pharmaceutical retailer stocks were down -5.74% in the last day, and down -5.67% over the last week. Rite Aid was the among the top losers in the pharmaceutical retailers industry, dropping -28.02% yesterday.

Rite Aid shares are trading lower after the company reported worse-than-expected Q2 EPS and lowered its FY23 adjusted EBITDA guidance. The company also said it expects continued pressure on consumer spending and supply chain challenges.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

Walgreens Boots Alliance (NASDAQ:WBA) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Walgreens Boots Alliance has a valuation score of 57, which is 27 points higher than the pharmaceutical retailer industry average of 30. It passed 4 out of 7 valuation due diligence checks.

Walgreens Boots Alliance's stock has dropped -35.23% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 27 percentage points.

Greenlane Holdings (NASDAQ:GNLN) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Greenlane Holdings has a valuation score of 43, which is 13 points higher than the pharmaceutical retailer industry average of 30. It passed 3 out of 7 valuation due diligence checks.

Greenlane Holdings's stock has dropped -96.28% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -34 percentage points.

Petmed Express (NASDAQ:PETS) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Petmed Express has a valuation score of 43, which is 13 points higher than the pharmaceutical retailer industry average of 30. It passed 3 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -29.61% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 32 percentage points.